Esperion Therapeutics Inc (NASDAQ:ESPR)

101.22
Delayed Data
As of Apr 17
 -0.125 / -0.12%
Today’s Change
12.76
Today|||52-Week Range
118.95
+150.30%
Year-to-Date
No recent news for Esperion Therapeutics Inc.

Today’s Trading

Previous close101.35
Today’s open100.70
Day’s range98.83 - 102.15
Volume403,037
Average volume (3 months)926,045
Market cap$2.3B
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+32.93%
Earnings growth (this year)-6.57%
Earnings growth (next 5 years)-27.02%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book15.44

Competitors

 Today’s
change
Today’s
% change
NVAXNovavax Inc-0.16-1.94%
HALOHalozyme Therapeutic...-0.22-1.42%
KITEKite Pharma Inc-0.21-0.32%
OPHTOphthotech Corp-1.23-2.37%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$0.00
Annual profit (last year)-$36.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Scientific Officer
Roger S. Newton
President, Chief Executive Officer &
Director
Tim M. Mayleben
Corporate headquarters
Ann Arbor, Michigan

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers